Posted to Announcement on 3/29/2011 at 9:56 AM
CSL Limited (ASX:CSL) Australia’s leading biopharmaceutical company, has announced a change to its senior executive group. Peter Turner, President of CSL Behring in King of Prussia, PA, will hand over his responsibilities as President to Paul Perreault effective July 1, 2011.
Paul Perreault is currently a member of the CSL Behring leadership team holding the position Executive Vice President, Commercial Operations. His career spans 30 years in the pharmaceutical industry in sales, marketing, business development and operational roles with both a US and international focus.
The announcement can be viewed in its entirety at http://www.csl.com.au/s1/cs/auhq/1182280826145/news/1255926123898/prdetail.htm
Related Link: Click to View
Related File: Click to View
Share This Post With Others